GoodRx launches $39 weight-loss telehealth plan and a $199 introductory Ozempic and Wegovy price
GoodRx is pairing a low-cost telehealth subscription with a $199 introductory cash price for starter doses of Ozempic and Wegovy, though the discount covers only the first two fills of the lowest doses.
GoodRx announced on Nov. 17, 2025 that it is launching a weight-loss telemedicine subscription at an introductory $39 a month and offering first-time users an introductory cash price of $199 a month for Ozempic and Wegovy injection pens [1].
The subscription
GoodRx for Weight Loss connects consumers with licensed healthcare providers who evaluate whether a person is eligible and, if appropriate, write a prescription for an FDA-approved GLP-1 medication for weight loss [1]. The service also includes ongoing clinical support to track progress, manage side effects and adjust treatment [1].
Medications are priced separately from the subscription, so members pay only for the prescriptions they fill, the company said [1]. The subscription costs $39 a month at an introductory rate through January 2026, then moves to a standard price of $119 a month starting Feb. 1, 2026 [1].
The $199 price
Under a partnership with Novo Nordisk, GoodRx is offering Ozempic (semaglutide) and Wegovy (semaglutide) injection pens at $199 a month to first-time GoodRx users for the first two fills of the two lowest doses, 0.25 mg and 0.5 mg [1]. After those first two fills, the price is $349 a month [1].
The offer is valid through March 31, 2026, and GoodRx says the self-pay cost for Ozempic 2.0 mg remains $499 [1]. The prices are cash prices available at nearly all pharmacies nationwide, according to the company [1].
On fulfillment, GoodRx lists in-store pickup at nearly all retail pharmacy locations for Wegovy or Zepbound (tirzepatide) pens, or home delivery for the Zepbound vial formulation through LillyDirect [1]. GoodRx says the subscription is aimed at FDA-approved medications rather than compounded alternatives [1].
GoodRx describes its savings as "the lowest cash prices available for any FDA-approved GLP-1 medications for weight loss treatment," a characterization the company makes in its own announcement [1]. Wendy Barnes, president and CEO of GoodRx, said the company is "committed to connecting consumers with FDA-approved GLP-1 medications backed by science and safety, not compounded alternatives that fall short of those standards" [1].
GoodRx says it is used by nearly 30 million consumers and more than one million healthcare professionals a year, and that it has helped Americans save more than $85 billion on medications since 2011 [1].
Why it matters for patients
Cash prices are a central obstacle for people who take GLP-1 medications without insurance coverage for weight loss, and the announced price cuts lower the entry cost for the first weeks of treatment. But the discount is narrow. The $199 rate applies only to first-time GoodRx users, only to the two lowest doses and only to the first two fills [1]. Someone who continues treatment past two months, or moves to a higher dose, moves to the $349 monthly price, while Ozempic 2.0 mg stays at $499 on a self-pay basis [1].
Medication is billed separately from the telemedicine subscription, which adds $39 a month at the introductory rate and $119 a month once the standard price begins on Feb. 1, 2026 [1]. A prescription is still required, and a licensed provider decides whether a person is eligible [1].
Several details have not been disclosed. The company says the prices are available at nearly all pharmacies nationwide but has not given a specific count [1]. Whether insurance plans will cover these cash prices has not been reported, and GoodRx has not said what happens to pricing after the March 31, 2026 offer ends [1]. GoodRx also did not say in the announcement whether similar discounts will apply to other GLP-1 medications, including tirzepatide products such as Zepbound [1].
What happens next
Feb. 1, 2026: the GoodRx for Weight Loss subscription moves from the introductory $39 rate to a standard $119 a month [1].
March 31, 2026: the $199 introductory price for Ozempic and Wegovy expires; the company lists $349 a month as the ongoing price after the first two fills [1].
Sources
Semaglutides.org provides information only, not medical advice. Talk to a licensed provider about your own care before making changes. Some telehealth links are affiliate links and are labeled where they appear.